Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Houston TX, San Antonio TX, Dallas TX, Nashville TN,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase 1, Recruiting

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

for
Hemophilia B
Location: Houston TX, Ann Arbor MI, Pittsburgh PA, Hamilton,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT06003387

Phase 3, Recruiting

A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium

for
Hypoactive Delirium
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05837039

Recruiting

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

for
Hematopoietic and Lymphoid Cell Neoplasm, Influenza
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT04712539

Phase 2, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Houston TX, San Antonio TX, Fort Worth TX,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

for
Endometrial Clear Cell Adenocarcinoma,
Location: Houston TX, Maywood IL, Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 0+

Code: NCT03422198

Phase 3, Recruiting

Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies

for
Recurrent Ependymoma, Recurrent Medulloblastoma,
Location: Houston TX
Sponsor: Jeffrey Treiber

Sex: All

Age: 1 - 70+

Code: NCT06466798

Phase 1, Recruiting

A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

for
Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06563505

Phase 2, Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Houston TX, San Antonio TX, Dallas TX, New Orleans LA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase 1, Phase 2, Recruiting

Negative Pressure Wound Therapy Registry

for
Diabetic Foot Ulcers, Venous Stasis Ulcer, Pressure Ulcer,
Location: The Woodlands TX
Sponsor: U.S. Wound Registry

Sex: All

Age: 0+

Code: NCT02467998

Recruiting

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension

for
Difficult to Control Hypertension
Location: Houston TX, Richmond TX, Mansfield TX, Dallas TX,
Sponsor: E-Star BioTech, LLC

Sex: All

Age: 18 - 70+

Code: NCT06343298

Phase 2, Recruiting

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

for
Prediabetic State, Atherosclerosis, Metformin
Location: Houston TX, Dallas TX, Little Rock AR, Memphis TN,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT02915198

Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Houston TX, Birmingham AL, Nashville TN, St Louis MO,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase 1, Phase 2, Recruiting

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

for
Primary Myelofibrosis
Location: Houston TX, Kansas City KS, St Louis MO, Tampa FL,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06343805

Phase 1, Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: Sugar Land TX, San Antonio TX, Grapevine TX, Tulsa OK,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase 3, Recruiting

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

for
Stage II Vulvar Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04169763

Phase 1, Recruiting

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia

for
Achondroplasia
Location: Houston TX, Madison WI, Saint Paul MN, Montreal
Sponsor: Ascendis Pharma A/S

Sex: All

Age: 0 - 2

Code: NCT06079398

Phase 2, Recruiting

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

for
Advanced Solid Tumor, Homologous Recombination Deficiency,
Location: Houston TX, Shreveport LA, Durham NC, Seattle WA
Sponsor: Eisbach Bio GmbH

Sex: All

Age: 18+

Code: NCT06525298

Phase 1, Phase 2, Recruiting

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

for
Gastric Adenocarcinoma, Carcinomatosis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05977998

Phase 2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Houston TX, San Antonio TX, Dallas TX, Baton Rouge LA,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting
Article preview image

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City